Differential gene expression of somatotrophic and growth factors in response to in vivo hypoxia in human placenta

Am J Obstet Gynecol. 2007 Dec;197(6):601.e1-6. doi: 10.1016/j.ajog.2007.04.008.

Abstract

Objective: Hypoxia-inducible transcription factors (HIFs) have been characterized as the most important regulators of O(2)-dependent gene transcription. We investigated expression of HIF-dependent growth factors and HIF-independent somatotrophic factors in term placenta in response to hypoxic ischemia.

Study design: Our cross-sectional in vivo analysis included term placentas of gestations complicated by the following: (1) birth asphyxia (n = 22); (2) chronic hypoxic ischemia (n = 22); and (3) controls (n = 28). Gene expression of leptin, insulin-like growth factor (IGF)-1, IGF-2, ghrelin, and human placental growth hormone (hPGH) were measured by TaqMan reverse transcriptase-polymerase chain reaction.

Results: Acute and chronic hypoxia significantly increased leptin messenger ribonucleic acid (mRNA) levels, compared with controls (P < .001). Augmented IGF-2 mRNA levels were present in chronic hypoxia (P < .001) but not in birth asphyxia. IGF-1, ghrelin, and hPGH mRNA levels did not change in relation to hypoxia.

Conclusion: IGF-2 and leptin are suggested to be involved in adaptive response to hypoxic ischemia in term placenta with differential transcriptional regulation related to the duration of hypoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Gene Expression
  • Humans
  • Hypoxia / etiology
  • Hypoxia / genetics*
  • Infant, Newborn
  • Insulin-Like Growth Factor II / genetics
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Ischemia / complications
  • Ischemia / genetics*
  • Leptin / genetics
  • Placenta / blood supply
  • Placenta / physiology*

Substances

  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Insulin-Like Growth Factor II